TY - JOUR
T1 - Effect of Volatile Anesthetics on Myocardial Infarction After Coronary Artery Surgery
T2 - A Post Hoc Analysis of a Randomized Trial
AU - MYRIAD Study Group
AU - Zangrillo, Alberto
AU - Lomivorotov, Vladimir V.
AU - Pasyuga, Vadim V.
AU - Belletti, Alessandro
AU - Gazivoda, Gordana
AU - Monaco, Fabrizio
AU - Nigro Neto, Caetano
AU - Likhvantsev, Valery V.
AU - Bradic, Nikola
AU - Lozovskiy, Andrey
AU - Lei, Chong
AU - Bukamal, Nazar A.R.
AU - Silva, Fernanda Santos
AU - Bautin, Andrey E.
AU - Ma, Jun
AU - Yong, Chow Yen
AU - Carollo, Cristiana
AU - Kunstyr, Jan
AU - Wang, Chew Yin
AU - Grigoryev, Evgeny V.
AU - Riha, Hynek
AU - Wang, Chengbin
AU - El-Tahan, Mohamed R.
AU - Scandroglio, Anna Mara
AU - Mansor, Marzida
AU - Lembo, Rosalba
AU - Ponomarev, Dmitry N.
AU - Bezerra, Francisco José Lucena
AU - Ruggeri, Laura
AU - Chernyavskiy, Alexander M.
AU - Xu, Junmei
AU - Tarasov, Dmitry G.
AU - Navalesi, Paolo
AU - Yavorovskiy, Andrey
AU - Bove, Tiziana
AU - Kuzovlev, Artem
AU - Hajjar, Ludhmila A.
AU - Landoni, Giovanni
N1 - Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/8
Y1 - 2022/8
N2 - Objective: To investigate the effect of volatile anesthetics on the rates of postoperative myocardial infarction (MI) and cardiac death after coronary artery bypass graft (CABG). Design: A post hoc analysis of a randomized trial. Setting: Cardiac surgical operating rooms. Participants: Patients undergoing elective, isolated CABG. Interventions: Patients were randomized to receive a volatile anesthetic (desflurane, isoflurane, or sevoflurane) or total intravenous anesthesia (TIVA). The primary outcome was hemodynamically relevant MI (MI requiring high-dose inotropic support or prolonged intensive care unit stay) occurring within 48 hours from surgery. The secondary outcome was 1-year death due to cardiac causes. Measurements and Main Results: A total of 5,400 patients were enrolled between April 2014 and September 2017 (2,709 patients randomized to the volatile anesthetics group and 2,691 to TIVA). The mean age was 62 ± 8.4 years, and the median baseline ejection fraction was 57% (50-67), without differences between the 2 groups. Patients in the volatile group had a lower incidence of MI with hemodynamic complications both in the per-protocol (14 of 2,530 [0.6%] v 27 of 2,501 [1.1%] in the TIVA group; p = 0.038) and as-treated analyses (16 of 2,708 [0.6%] v 29 of 2,617 [1.1%] in the TIVA group; p = 0.039), but not in the intention-to-treat analysis (17 of 2,663 [0.6%] v 28 of 2,667 [1.0%] in the TIVA group; p = 0.10). Overall, deaths due to cardiac causes were lower in the volatile group (23 of 2,685 [0.9%] v 40 of 2,668 [1.5%] than in the TIVA group; p = 0.03). Conclusions: An anesthetic regimen, including volatile agents, may be associated with a lower rate of postoperative MI with hemodynamic complication in patients undergoing CABG. Furthermore, it may reduce long-term cardiac mortality.
AB - Objective: To investigate the effect of volatile anesthetics on the rates of postoperative myocardial infarction (MI) and cardiac death after coronary artery bypass graft (CABG). Design: A post hoc analysis of a randomized trial. Setting: Cardiac surgical operating rooms. Participants: Patients undergoing elective, isolated CABG. Interventions: Patients were randomized to receive a volatile anesthetic (desflurane, isoflurane, or sevoflurane) or total intravenous anesthesia (TIVA). The primary outcome was hemodynamically relevant MI (MI requiring high-dose inotropic support or prolonged intensive care unit stay) occurring within 48 hours from surgery. The secondary outcome was 1-year death due to cardiac causes. Measurements and Main Results: A total of 5,400 patients were enrolled between April 2014 and September 2017 (2,709 patients randomized to the volatile anesthetics group and 2,691 to TIVA). The mean age was 62 ± 8.4 years, and the median baseline ejection fraction was 57% (50-67), without differences between the 2 groups. Patients in the volatile group had a lower incidence of MI with hemodynamic complications both in the per-protocol (14 of 2,530 [0.6%] v 27 of 2,501 [1.1%] in the TIVA group; p = 0.038) and as-treated analyses (16 of 2,708 [0.6%] v 29 of 2,617 [1.1%] in the TIVA group; p = 0.039), but not in the intention-to-treat analysis (17 of 2,663 [0.6%] v 28 of 2,667 [1.0%] in the TIVA group; p = 0.10). Overall, deaths due to cardiac causes were lower in the volatile group (23 of 2,685 [0.9%] v 40 of 2,668 [1.5%] than in the TIVA group; p = 0.03). Conclusions: An anesthetic regimen, including volatile agents, may be associated with a lower rate of postoperative MI with hemodynamic complication in patients undergoing CABG. Furthermore, it may reduce long-term cardiac mortality.
UR - https://www.scopus.com/pages/publications/85124472941
UR - https://www.scopus.com/pages/publications/85124472941#tab=citedBy
U2 - 10.1053/j.jvca.2022.01.001
DO - 10.1053/j.jvca.2022.01.001
M3 - Article
C2 - 35168907
AN - SCOPUS:85124472941
SN - 1053-0770
VL - 36
SP - 2454
EP - 2462
JO - Journal of cardiothoracic and vascular anesthesia
JF - Journal of cardiothoracic and vascular anesthesia
IS - 8
ER -